Lung Cancers Withdrawn Phase 3 Trials for Efaproxiral (DB08486)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00055887Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment